Key points are not available for this paper at this time.
You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy of the five, 2 were on AS/WW and 3 had new PCa diagnosis (Figure 1). Median follow-up after surgery was 14 months. Table 1 lists oncologic and surgical outcomes. CONCLUSIONS: RASP is safe and effective in men with a prior diagnosis of PCa or with new diagnosis of PCa on RASP pathology. Few men undergoing RASP in our cohort proceeded to radical therapy for PCa. Nonetheless, patients on AS/WW undergoing RASP or those with PCa diagnosed on RASP specimen should be monitored for progression of PCa warranting further intervention. Download PPT Source of Funding: Unfunded © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e328 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Dylan Buller More articles by this author Ilene Staff More articles by this author Tara McLaughlin More articles by this author Kevin Pinto More articles by this author Laura Olivo Valentin More articles by this author Joseph Tortora More articles by this author David Ahlborn More articles by this author Brandon Stahl More articles by this author Ryan Dorin More articles by this author Stuart Kesler More articles by this author Joseph Wagner More articles by this author Expand All Advertisement PDF downloadLoading ...
Buller et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: